The Taisho Pharmaceutical Group’s (hereinafter “the Group”) mission is to contribute to society by creating and offering superior pharmaceuticals and health-related products as well as healthcare-related information and services in socially responsible ways that enrich people’s lives by improving health and beauty. Guided by this mission, we are working to develop attractive products and actively provide information, among other priorities. At the same time, we strive to become a pharmaceutical manufacturer capable of covering a variety of needs from enhancing health and preventive measures to treatment.

In recent years, Japan has seen burgeoning social insurance expenses due to the country’s aging society and low birthrate become a major issue. Moreover, the Group’s operating environment has changed dramatically, driven by structural changes in the market, rising health consciousness among consumers and other factors. Against this backdrop, the Group has actively tackled various issues in response to its changing business environment, to answer consumer needs. And on October 3, 2011, we transitioned to a holding company system by establishing Taisho Pharmaceutical Holdings Co., Ltd. through a sole-share transfer. The goal is to ensure that we remain on a sustainable growth path as we lay even stronger business foundations going forward.

• Company: Taisho Pharmaceutical (M) Sdn Bhd
• Legal Representative: Hiroya Fukatsu
• Year Established: 1990
• Address: Unit B-3A-3A, 3 Two Square N0.2 Jalan 19/1, 46300 Petaling Jaya Selangor, Malaysia
• Phone: +603-7931 1628
• Fax: +603-7932 0122
• Website: taisho-holdings.co.jp

Products: Energy Drinks: Vitamin Healthy Beverage (LIVITA)